Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Ohashi R, Martignoni G, Hartmann A, Caliò A, Segala D, Stöhr C, Wach S, Erlmeier F, Weichert W, Autenrieth M, Schraml P, Rupp NJ, Ohe C, Otsuki Y, Kawasaki T, Kobayashi H, Kobayashi K, Miyazaki T, Shibuya H, Usuda H, Umezu H, Fujishima F, Furusato B, Osakabe M, Sugai T, Kuroda N, Tsuzuki T, Nagashima Y, Ajioka Y, Moch H. Ohashi R, et al. Among authors: autenrieth m. Virchows Arch. 2020 Mar;476(3):409-418. doi: 10.1007/s00428-019-02710-w. Epub 2019 Nov 23. Virchows Arch. 2020. PMID: 31760491
[c-MET Oncogene in Renal Cell Carcinomas].
Erlmeier F, Weichert W, Autenrieth M, Ivanyi P, Hartmann A, Steffens S. Erlmeier F, et al. Among authors: autenrieth m. Aktuelle Urol. 2016 Dec;47(6):475-479. doi: 10.1055/s-0042-115401. Epub 2016 Dec 22. Aktuelle Urol. 2016. PMID: 28006830 Review. German.
c-Met in chromophobe renal cell carcinoma.
Erlmeier F, Ivanyi P, Hartmann A, Autenrieth M, Wiedemann M, Weichert W, Steffens S. Erlmeier F, et al. Among authors: autenrieth m. Med Oncol. 2017 Feb;34(2):15. doi: 10.1007/s12032-016-0874-1. Epub 2016 Dec 29. Med Oncol. 2017. PMID: 28035577
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?
Erlmeier F, Weichert W, Autenrieth M, Wiedemann M, Schrader AJ, Hartmann A, Ivanyi P, Steffens S. Erlmeier F, et al. Among authors: autenrieth m. Med Oncol. 2017 May;34(5):71. doi: 10.1007/s12032-017-0926-1. Epub 2017 Mar 28. Med Oncol. 2017. PMID: 28353093
Prognostic impact of PD-1 and its ligands in renal cell carcinoma.
Erlmeier F, Weichert W, Schrader AJ, Autenrieth M, Hartmann A, Steffens S, Ivanyi P. Erlmeier F, et al. Among authors: autenrieth m. Med Oncol. 2017 Jun;34(6):99. doi: 10.1007/s12032-017-0961-y. Epub 2017 Apr 21. Med Oncol. 2017. PMID: 28432616 Review.
Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme.
Ohashi R, Martignoni G, Hartmann A, Caliò A, Segala D, Stöhr C, Wach S, Erlmeier F, Weichert W, Autenrieth M, Schraml P, Rupp NJ, Ohe C, Otsuki Y, Kawasaki T, Kobayashi H, Kobayashi K, Miyazaki T, Shibuya H, Usuda H, Umezu H, Fujishima F, Furusato B, Osakabe M, Sugai T, Kuroda N, Tsuzuki T, Nagashima Y, Ajioka Y, Moch H. Ohashi R, et al. Among authors: autenrieth m. Virchows Arch. 2020 Mar;476(3):419-422. doi: 10.1007/s00428-020-02786-9. Virchows Arch. 2020. PMID: 32157467
The synergism of spatial metabolomics and morphometry improves machine learning-based renal tumour subtype classification.
Prade VM, Sun N, Shen J, Feuchtinger A, Kunzke T, Buck A, Schraml P, Moch H, Schwamborn K, Autenrieth M, Gschwend JE, Erlmeier F, Hartmann A, Walch A. Prade VM, et al. Among authors: autenrieth m. Clin Transl Med. 2022 Feb;12(2):e666. doi: 10.1002/ctm2.666. Clin Transl Med. 2022. PMID: 35184396 Free PMC article. No abstract available.
57 results